Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Biosig Technologies
(NQ:
BSGM
)
1.301
+0.001 (+0.05%)
Streaming Delayed Price
Updated: 2:05 PM EDT, Apr 26, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Biosig Technologies
< Previous
1
2
Next >
Global Cardiac Arrhythmia Monitoring Devices Market Size Expected to Reach $11.4 Billion by 2030
December 14, 2022
Palm Beach, FL – December 14, 2022 – FinancialNewsMedia.com News Commentary – A cardiac arrhythmia is an irregular heartbeat caused by incorrect electrical signals that govern the beats of the heart....
Via
FinancialNewsMedia
BioSig’s PURE EP™ System Demonstrates Potential Time and Cost Savings at the 15th APHRS Scientific Session in Singapore
December 14, 2022
Abstract highlights promising results from PURE EP™ study at premier Asia-Pacific Heart Rhythm Society Conference
From
BioSig Technologies, Inc.
Via
GlobeNewswire
BioSig’s PURE EP™ System Highlighted in the Journal of Atrial Fibrillation & Electrophysiology
December 06, 2022
Clinical abstract focuses on value of PURE EP™’s and its groundbreaking High Frequency Algorithm (HFA) during pulmonary vein isolation
From
BioSig Technologies, Inc.
Via
GlobeNewswire
BioSig Signs Master Research Agreement with Cleveland Clinic to Explore Expanded Applications for its Digital Signal Processing Technology
October 24, 2022
From
BioSig Technologies, Inc.
Via
GlobeNewswire
BioSig Invited to Attend and Sponsor Venice Arrhythmias 2022
October 12, 2022
Company to introduce its novel digital signal processing technology to the European EP community at world-renown international congress
From
BioSig Technologies, Inc.
Via
GlobeNewswire
BioSig Executes Purchase Agreement with Methodist Hospital, San Antonio and Expands Customer Base
October 07, 2022
Leading medical center in San Antonio acquires BioSig’s novel digital signal processing technology for arrhythmia care
From
BioSig Technologies, Inc.
Via
GlobeNewswire
This NASDAQ is Cardiac Worthy: Patent Protected Signal Processing Advancements for Cardiac Arrhythmia Nearing Commercialization: BioSig Technologies (NASDAQ: BSGM)
March 29, 2022
Via
Get News
Topics
Intellectual Property
Exposures
Intellectual Property
BioSig Expands its Installation Base in Texas
November 04, 2021
Signs a new installation agreement with high-volume center in San Antonio Westport, CT – November 04, 2021 – BioSig Technologies, Inc. (Nasdaq: BSGM) (“BioSig” or the “Company”), a medical technology...
Via
FinancialNewsMedia
Increasing Incidences of Cardiac Arrhythmias Raising Demand for Electrophysiology Medical Devices
September 21, 2021
Via
FinancialNewsMedia
Atrial Fibrillation Market Is Expected To Reach $11.123 Billion At A CAGR 11.2 % Through 2023
November 04, 2021
Palm Beach, FL – November 4, 2021 – FinancialNewsMedia.com News Commentary – Atrial fibrillation is an ailment in which the heart beats irregularly, unlike the usual heartbeat. The upper chambers of...
Via
FinancialNewsMedia
Topics
Death
Exposures
Death
BioSig Technologies, Inc. Appoints Medical Device Industry Leader to its Board of Directors
September 21, 2021
Via
FinancialNewsMedia
The Global Electrophysiology Market Is Projected To Reach $10.6 Billion By 2025
June 30, 2021
Via
FinancialNewsMedia
BioSig Completes 1000 Patient Cases with its Signal Processing System for Electrophysiology
June 30, 2021
Via
FinancialNewsMedia
< Previous
1
2
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.